tradingkey.logo

Maze Therapeutics Inc

MAZE

23.480USD

-0.020-0.09%
Close 09/18, 16:00ETQuotes delayed by 15 min
1.03BMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q4
FY2023Q3
Total revenue
--0.00
----
--0.00
--2.50M
----
--0.00
Revenue
--0.00
----
--0.00
--2.50M
----
--0.00
Operating expenses
--36.47M
--35.40M
28.96%29.73M
5.95%26.73M
--23.05M
--25.23M
R&D expenses
--28.11M
--27.58M
38.46%22.22M
2.05%19.86M
--16.05M
--19.46M
Depreciation, depletion, and amortization
--649.00K
--684.00K
-28.57%705.00K
-21.51%788.00K
--987.00K
--1.00M
Operating profit
---36.47M
---35.40M
-28.96%-29.73M
3.96%-24.23M
---23.05M
---25.23M
Net non-operating interest income (expenses)
Special income (expenses)
----
----
57.08%-1.64M
---2.65M
---3.83M
--0.00
Income before tax
---33.68M
---32.79M
-12.33%-29.85M
-1.15%-25.03M
---26.58M
---24.75M
Income tax
--0.00
----
---275.00K
---279.00K
----
--0.00
Equity earnings after tax
----
----
--39.65M
--22.32M
----
--0.00
Income after tax
---33.68M
---32.79M
-11.30%-29.58M
-0.02%-24.75M
---26.58M
---24.75M
Net income from continuous operations
---33.68M
---32.79M
137.87%10.07M
90.19%-2.43M
---26.58M
---24.75M
Net income attributable to controlling interests
---33.68M
---32.79M
81.54%-4.91M
90.19%-2.43M
---26.58M
---24.75M
Preferred share dividend
----
----
--14.97M
----
----
----
Net income attributable to common shareholders
---33.68M
---32.79M
81.54%-4.91M
90.19%-2.43M
---26.58M
---24.75M
Basic earnings per share
---0.77
---1.15
81.54%-0.11
90.19%-0.06
---0.61
---0.57
Diluted earnings per share
---0.77
---1.15
81.54%-0.11
90.19%-0.06
---0.61
---0.57
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
KeyAI